retatrutide trial news Lilly's Scores Triple Triumph With 26% Weight Loss, But New Safety Signal Emerges Phase III retatrutide study demonstrates

California Prop 65 Notice: WARNING: Consuming this product can expose you to chemicals including those listed under California Proposition 65 (Prop 65)

In 2025, 24.3% of Americans who had ever taken a GLP-1 reported using a compounded version, and 11% of consumers obtained their GLP-1 medications through online platforms

Exenatide is a synthetic form of a protein originally isolated from the saliva of the Gila monster (poisonous lizard that lives in the deserts of Arizona)(Triplitt & Chiquette, 2003)

Clinical trials examining Retatrutide have tested a range of amounts to observe how the compound performs at different levels, including its effects on appetite regulation, metabolic markers, and overall tolerability

In most clinical trials, participants who lost the most weight combined medication with changes to diet and regular exercise